High pleural fluid adenosine deaminase levels : a valuable tool for rapid diagnosis of pleural TB in a middle-income country with a high TB/HIV burden by Onyenekwu, C. P. et al.
RESEARCH
200       March 2014, Vol. 104, No. 3
The burden of tuberculosis (TB) in South Africa 
(SA) is the third highest in the world after China and 
India and contributes one quarter of the burden of TB 
in the World Health Organization (WHO) African 
region.[1] The incidence of TB in the Western Cape is 
higher than the national incidence rate of 823/100 000 population, at 
935/100 000 population.[2] Extrapulmonary TB constitutes 14.5% of TB 
cases in SA.[1] HIV/TB co-infection has been associated with pleural 
TB (PTB), a form of extrapulmonary TB.[3] Delays in the diagnosis 
of TB and the initiation of therapy, in addition to the high HIV/TB 
co-infection rates, are some of the obstacles to the achievement of the 
sixth millennium development goal in the WHO African region.[1]
The diagnosis of PTB using traditional methods is challenging 
due to the low sensitivity of routine TB diagnostic tools,[4] viz. 
sputum smear microscopy (developed over 100 years ago and the 
most common method for TB diagnosis worldwide), culture for 
Mycobacterium tuberculosis (the current reference standard for TB 
diagnosis), and polymerase chain reaction-based techniques and 
rapid molecular tests (developed more recently for TB diagnosis and 
diagnosis of drug-resistant TB).[1]
About 35 years ago, Piras et al.[5] first observed that adenosine 
deaminase (ADA), a zinc-containing metalloenzyme expressed in high 
levels by lymphocytes and monocytes, was elevated in PTB. Since then, 
several authors have confirmed this finding, supporting the use of high 
pleural fluid ADA (FADA) as a simple, rapid, sensitive, cost-effective 
and robust diagnostic tool for PTB.[6-10] This led to its widespread 
implementation and routine utilisation in countries such as SA with a 
high prevalence of TB. However, high FADA levels can also occur in 
other disease conditions and particularly in empyemas, lymphomas, 
carcinomas and parapneumonic effusions due to proliferation of large 
numbers of neutrophils and lymphocytes in these conditions, resulting 
in false-positive results and misdiagnosis.[11] The usefulness of FADA in 
the diagnosis of PTB depends on the prevalence of TB. In populations 
with a high prevalence, the sensitivity and specificity may be as high as 
95% and 90%, respectively, but in low prevalence areas, the specificity 
can be considerably lower.[12]
An essential component of clinical practice is the use of clinical 
laboratory test results in diagnostic decision-making; hence, there 
is a need for every diagnostic tool to be reliable, relevant and cost-
effective, particularly in a middle-income country where the disease 
burden is high. 
In response to queries from clinicians concerning the possible high 
false-positive (FP) rate of the FADA test in our laboratory, with many 
negative TB culture results, we performed a retrospective audit of all 
the high FADA results generated over a 1-year period. 
Objectives
To determine (i) the positive predictive value (PPV) of high FADA 
test results for PTB; (ii) the most common causes of FPs and the 
demographic characteristics of tuberculous pleural effusions (TPEs) 
and non-tuberculous pleural effusions (NTPEs); (iii) the frequency 
of TPEs in HIV-positive and HIV-negative patients with pleural 
effusions; and (iv) the FADA levels in TPEs and NTPEs and in HIV-
positive and -negative patients.
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Background. South Africa has the highest burden of tuberculosis (TB) in the World Health Organization (WHO) African region. Using 
traditional TB diagnostic tools, the diagnosis of pleural TB (PTB) is highly unrewarding. Elevated levels of pleural fluid adenosine 
deaminase (FADA) have been shown to be useful in the diagnosis of PTB; however, similar levels may be found in some other medical 
conditions leading to misdiagnosis. Following queries from clinicians concerning the likely high false-positive (FP) rate of FADA from our 
laboratory, we performed a retrospective audit of all high FADA results generated over a 12-month period. 
Objectives. To determine the positive predictive value (PPV) of FADA, the frequent causes of FPs in our laboratory and the demographic 
characteristics of tuberculous pleural effusions (TPEs) and non-tuberculous pleural effusions (NTPEs).
Methods. High FADA results generated in the past year were extracted with corresponding TB culture results, fluid cell count, cytology/
histology results, radiology reports and HIV results. Hospital records were reviewed for the final diagnosis in each case. Diagnosis of PTB 
was based on the WHO case definition of TB.
Results. A total of 159 results were reviewed: 133 (83.6%) were TPE, hence FADA had a PPV of 83.6%. Neoplasm was the most common cause 
of an FP in 13/26 (50%) NTPEs. While TPE was more common than NTPE in younger people, both groups had an equal gender distribution.
Conclusion. FADA had a high PPV for PTB in our laboratory. We recommend its continued use as a rapid and reliable diagnostic tool for PTB.
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Methods
Study setting and design
High FADA results generated at the Chemical 
Pathology Laboratory, Tygerberg Hospital 
(TH), over a 1-year period from 1 January to 
31 December 2012 were reviewed. The hospital 
serves ~5.8 million people residing within the 
Western Cape, also serving as a referral centre 
for many hospitals and primary healthcare 
clinics in the region. The laboratory at TH is 
an accredited facility, which serves the hospital 
and satellite hospitals within the Western Cape; 
it receives up to 1 000 ADA requests annually, 
including non-pleural fluid specimens such as 
cerebrospinal, ascitic, pericardial and synovial 
fluids.
Ethical approval for the audit was 
granted by the Health Research and Ethics 
Committee of Stellenbosch University, 
Tygerberg, SA. The audit was performed 
according to the Declaration of Helsinki. 
As this was a retrospective study and 
patient consent had been obtained prior 
to thoracocentesis, the need for individual 
patient consent for this study was waived by 
the ethics committee. Patient confidentiality 
was maintained throughout.
Study criteria included all high (≥30  U/l) 
FADA results generated within the study 
period, from patients managed within TH, 
with corresponding TB culture requests. 
We excluded non-pleural fluid ADA results, 
empyemas, high FADA results without TB 
culture results, requests from satellite hospitals 
and requests with lost patient records.
Specimens for ADA assays were collected 
in plain tubes and stored at 2 - 8oC before 
analysis. Laboratory analysis was performed 
on a weekly basis. Turbid or bloody 
specimens were centrifuged and haemolysed 
and grossly purulent samples were rejected.
FADA activity was determined manually 
by spectrophotometry using the Giusti and 
Galanti method.[13] It is based on the enzymatic 
deamination of adenosine to inosine, with the 
release of ammonia which is determined 
by Berthelot’s reaction. One unit of ADA is 
defined as the amount of enzyme required 
to release 1 mmol/min of ammonia from 
adenosine at standard assay conditions. Each 
run was performed with a low- and a normal-
level quality control material.
FADA results meeting the study criteria 
were retrieved. Fluid cell count, HIV status, 
radiological, cytological and histological 
investigation reports were also extracted, 
where available. Patient hospital records 
were reviewed to obtain information on the 
final diagnosis. A diagnosis of TB was based 
on the WHO guidelines for case definitions 
of extrapulmonary TB.[14] The final diagnosis 
was classified into two broad groups of 
TPEs and NTPEs, with sub-classifications 
as follows:
• TPEs:
• TPE-I: Identification of M. tuberculosis 
complex in fluid or biopsy specimen 
by culture; histological evidence of 
granulomas and positive stain for acid-
fast bacilli (AFB) in pleural biopsy; and/
or positive sputum or gastric wash-out 
culture with clinical and radiological 
evidence of TB without any other cause 
for pleural effusion.
• TPE-II: The decision by a clinician to 
treat a patient with a full course of TB 
chemotherapy, based on strong clinical 
and radiological evidence, in the absence 
of other causes of pleural effusion.
• NTPEs:
• Neoplastic effusions: histological evi-
dence of a malignant effusion or a 
tumour, in the absence of other causes 
of pleural effusion.
• Parapneumonic effusions: identification 
of an organism in the pleural fluid or 
clinical and radiological evidence of 
pneumonia, with response to antibiotic 
therapy.
• Other: effusions due to conditions such 
as congestive cardiac failure, chronic liver 
disease, systemic lupus erythematosus 
and nephrotic syndrome.
Definition of true-positive (TP)  
and FP
• TP: FADA ≥30  U/l with the effusion 
fulfilling the criteria for TPE-I or TPE-II 
classification as defined above
• FP: FADA ≥30  U/l with the effusion 
fulfilling the criteria for NTPE classification 
as defined above.
Calculation of PPV
The PPV of FADA was calculated as: 
PPV = TP/[TP + FP].
Statistical analysis
Data were analysed using Statistica (version 
11.0). Continuous data are expressed as means 
(± standard deviations (SDs)). One-way 
analysis of variance (ANOVA) was employed 
and p<0.05 was considered significant.
Results 
A total of 614 FADA results were requested 
from within the hospital during the study 
period; 263 of these were high (≥30 U/l). After 
exclusion of 25 empyematous specimens, 61 
requests without corresponding TB micros-
copy and culture results, 12 duplicate results 
and 6 lost hospital records, a total of 159 
results were then analysed. There were 133 
(83.6%) TPE and 26 (16.4%) NTPE, the 
latter giving FADA a PPV of 83.6% for PTB. 
Males and females were equally distributed 
in both groups. A significantly younger age 
distribution was observed in the TPE group 
(Fig. 1). Table 1 shows a summary of the mean 
age and frequency of the 159 results according 
to aetiological classification and gender.
Employing the lymphocyte/neutrophil ratio, 
there was a slight but non-significant increase 
of the PPV of FADA to 89%. The mean 
(±SD) FADA level in the TPE group was 76.4 
(±29.1) U/l and slightly higher than that of the 
NTPE group 74.1 (±54.9) U/l. This difference 
was, however, not significant (Fig. 2). 
TB culture was positive in 75 (56.4%) of 
the TPE group (TPE-I), in the remaining 
58 (43.6%) TB culture-negative samples, 
classification as TPE was based on the 
fulfilment of criteria for TPE-II. Using 
microscopy techniques for AFB without 
culture, only 13 (9.8%) cases of TPE were 
positive. 
The HIV status was available for 118 (74.2%) 
patients, 56 (47.5%) of these were HIV-positive. 
Analysis of HIV/TB co-infection showed that a 
significantly higher number of 52 (93%) HIV-
positive patients were TB-positive compared 
with 52 (84%) HIV-negative patients who 
were TB-positive (p<0.05). One-way ANOVA 
for FADA levels and HIV status showed a 
mean (±SD) FADA of 74.4 (±36.3)  U/l in 
HIV-positive patients and this was lower than 
the mean (±SD) FADA of 78.7 (±32.7)  U/l 
observed in the patients who were HIV-
negative. This difference was, however, not 
statistically significant (Fig. 3).
Table 1. Demographic characteristics and aetiological classification of pleural effusion
Aetiology Frequency, n Sub-class (n)
Age (years) 
mean (±SD) Gender (n)
TPE 133 TPE-I (75)*
TPE-II (58)*
33.8 (±18.0) M (67)
F (66)
NTPE 26 Neoplastic (13)
Parapneumonic (7)
Others (6)
44.7 (±21.1) M (13)
F (13)
TPE = tuberculous pleural effusion; NTPE = non-tuberculous pleural effusion; SD = standard deviation; M = male; F= female.
*As defined in text.
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Discussion
The diagnosis of PTB is challenging due to the poor performance of 
the current gold standard for TB diagnosis – TB culture. Elevated 
FADA levels have been used as a fast and convenient adjunct 
diagnostic tool for PTB, particularly in areas with high TB burden. 
However, other conditions may also cause an increase in FADA 
levels with a negative TB culture. An effusion may be reactive, in 
which case the TB culture would be negative due to the absence 
of bacilli. The effusion may be paucibacillary in nature and the 
decontamination step performed prior to culture may decrease the 
number of bacilli, further decreasing the sensitivity of TB culture, 
resulting in a false-negative. Quality control procedures are put in 
place for TB culture, using an M.  tuberculosis H37RV strain as a 
positive control and phosphate buffer as a negative control with 
every batch of specimens at our laboratory. In response to queries 
from clinicians concerning many TB culture-negative results with 
high FADA results, we reviewed all high FADA results generated 
over the study period. Our main objectives were to assess the PPV 
of FADA for PTB and to determine the conditions that cause FPs 
and the demographic characteristics of TPE and NTPE with high 
FADA levels.
We observed a high PPV of 83.6%, which did not change 
significantly when the lymphocyte/neutrophil ratio was employed 
alongside, for the diagnosis of PTB. Of the NTPE, 13 (50%) were due 
to malignancies and nearly half of these were due to bronchial cancer, 
the other malignancies were single cases of ductal carcinoma of the 
breast, B cell lymphoma, parotid cancer, carcinoid tumour, basal cell 
carcinoma and infiltrating thymic tumour. A very poor sensitivity 
of 9.8% was observed for microscopy for AFB, while the reference 
standard for TB diagnosis, TB culture, had a sensitivity of 56.4%. 
TPEs occurred in a relatively younger age group than the NTPEs, but 
there was an equal gender distribution in the two groups. More HIV-
positive patients had TPEs than HIV-negative patients, although their 
FADA levels were not significantly different. 
Our finding of a PPV of 83.6% at a cut-off of 30  U/l was in 
agreement with that of Burgess et al.,[8] who also reported a PPV of 
84%, a negative predictive value (NPV) of 89%, sensitivity of 91% 
and specificity of 81%, though at a higher cut-off of 50 U/l. Zemlin 
et al.[10] observed similar diagnostic performance with FADA having a 
PPV of 85.5%, an NPV of 95.2%, sensitivity of 93.7% and specificity 
of 88.7% at an ADA cut-off of 52.4 U/l. A much higher PPV of 95% 
was reported by Riantawan et al. at a cut-off of 60U/l. [9] The non-
significant increase in the PPV when a lymphocyte/neutrophil ratio 
of ≥0.75 was combined with ADA, differs from observations by 
Burgess et al.[8] who recommended the combined use of ADA with 
differential fluid cell count, after an observed increase in specificity 
and PPV, for a more efficient diagnosis of PTB. This differing result 
may be due to the exclusion of empyematous effusions from our 
study. Empyemas are a known cause of elevated ADA and usually 
have a predominance of neutrophils. Nearly 10% of the high ADA 
results generated in our laboratory during the study period were due 
to empyemas, which had missed being rejected.
The poor sensitivity observed for the traditional diagnostic 
methods for PTB in the present study is a well-reported finding 
that makes diagnosis of PTB a challenge. The implication is that 
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Fig. 1. Age distribution of patients in tuberculous pleural effusion (TPE) and 
non-tuberculous pleural effusion (NTPE) groups. Current effect F(1, 157)  = 
7.5688; p≤0.010; Mann-Whitney U p<0.01. Vertical bars denote 95% 
confidence intervals.
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Fig.  2. Fluid adenosine deaminase (FADA) levels in tuberculous pleural 
effusions (TPEs) and non-tuberculous pleural effusions (NTPEs). Current 
effect F(1, 157) = 0.09741; p=0.76; Mann-Whitney U p=0.03. Vertical bars 
denote 95% confidence intervals.
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Fig. 3. Fluid adenosine deaminase (FADA) levels according to HIV status. 
Current effect F(1, 116) = 0.45747; p=0.50; Mann-Whitney U p=0.27. 
Vertical bars denote 95% confidence intervals.
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utilisation of either microscopy for AFB alone or TB culture of fluid 
would lead to many TB-positive patients being missed. 
Equal gender distribution seen in the TPE and NTPE groups differs 
from that of previous studies where there were generally slightly 
more males than females.[10,15] This may be due to changing patterns 
in access to healthcare, gender issues and changing epidemiological 
profiles, such as the rise of HIV infection particularly among 
women, which may contribute to the development of more TB 
cases in females.[16] We observed that more patients who were HIV-
positive had TPEs than patients who were HIV-negative. This is 
in agreement with the current epidemiological profile for TB/HIV 
co-infection rates.[1]
The older age distribution in the NTPE group might have been 
due to the aetiological conditions in this group, which are more 
common in older individuals. They consisted mainly of malignancies, 
parapneumonias and congestive cardiac failure. Most of the 
malignancies were due to bronchial cancer, which is in agreement 
with Zemlin et al.[10] Valdés et al.[17] found that parapneumonic 
effusions were the most frequent reason for a high FADA, followed by 
carcinomas (with pleural metastatic lesions) and lymphomas.
Study limitations
We reviewed only high FADA results and hence were not able to 
assess other measures of diagnostic accuracy apart from the PPV. 
However, previous studies have been carried out in our laboratory to 
assess the diagnostic accuracy of FADA for PTB,[8,10] which confirmed 
a high sensitivity and specificity. As the study was retrospective, 
high ADA results without corresponding microbiology results were 
excluded. In addition, the HIV status of the patients was not available 
in all cases. We excluded results of patients from satellite hospitals 
and clinics owing to difficulty in accessing the patient records from 
these facilities; however, this is unlikely to affect our findings as these 
hospitals, located within the Western Cape region, share a similar TB 
prevalence rate to that of TH.
Despite the limitations, we feel that this study is robust in that 
it reviews results over 1 year. We utilised the WHO-recognised 
reference standard for TB diagnosis as the gold standard in assessing 
for diagnosis of TB throughout. 
There is room for a similar but more extensive audit in future, 
involving FADA results from our hospital, other regional referral 
hospitals in the country and the satellite healthcare facilities utilising 
our laboratory services.
Conclusion
This audit has confirmed that high FADA results generated at our 
laboratory have a good precision rate for PTB. The few FPs that 
occurred are mostly due to malignancies, which occur in older people 
and can be diagnosed by cytology/histology and/or radiology, after 
confirming that the TB culture is negative. We reaffirm the fact that 
a high FADA is an indispensable TB diagnostic tool and recommend 
its continued use as a rapid means of diagnosing PTB in a middle-
income country with a high TB/HIV burden. 
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